These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7824958)

  • 21. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
    Xiao Z; Théroux P; Frojmovic M
    Thromb Haemost; 1999 Feb; 81(2):281-5. PubMed ID: 10064007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iminodipeptides containing proline with C-terminal and N-terminal residues prime the stimulation of human neutrophil superoxide generation by fMLP.
    Watanabe Y; Sagara Y; Sugahara K; Kodama H
    Biochem Biophys Res Commun; 1994 Nov; 205(1):758-64. PubMed ID: 7999109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet activation induced by FMLP-stimulated neutrophils.
    Selak MA; Chignard M; Smith JB
    Agents Actions Suppl; 1986; 20():99-107. PubMed ID: 3101445
    [No Abstract]   [Full Text] [Related]  

  • 24. Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood.
    Izzi B; Pampuch A; Costanzo S; Vohnout B; Iacoviello L; Cerletti C; de Gaetano G
    Thromb Haemost; 2007 Dec; 98(6):1276-84. PubMed ID: 18064325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-thromboglobulin and polymorphonuclear leukocytes activation. (Effects on chemiluminescence, release of membrane bound calcium, NADPH-oxidase activity and membrane fluidity).
    Allegrezza-Giulietti A; Serretti R; Beccerica E; Ferretti G; Cervini C
    Biochem Int; 1991 May; 24(2):273-9. PubMed ID: 1834061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
    Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin inhibits neutrophil-induced platelet activation via cathepsin G.
    Ferrer-Lopez P; Renesto P; Prevost MC; Gounon P; Chignard M
    J Lab Clin Med; 1992 Mar; 119(3):231-9. PubMed ID: 1541873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Farnesylcysteine analogs to probe role of prenylated protein methyltransferase.
    Ma YT; Gilbert BA; Rando RR
    Methods Enzymol; 1995; 250():226-34. PubMed ID: 7651154
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation of sulfate content and degree of carboxylation of heparin and related glycosaminoglycans with anticomplement activity. Relationships to the anticoagulant and platelet-aggregating activities.
    Cofrancesco E; Radaelli F; Pogliani E; Amici N; Torri GG; Casu B
    Thromb Res; 1979 Jan; 14(1):179-87. PubMed ID: 570740
    [No Abstract]   [Full Text] [Related]  

  • 31. [Behavior of the total polysaccharides and mucopolysaccharides in the leukocytes and platelets of normal and leukemic subjects].
    NOTARIO A; NESPOLI M
    Haematologica; 1961; 46():941-50. PubMed ID: 14480473
    [No Abstract]   [Full Text] [Related]  

  • 32. Specific targeting of antisense oligonucleotides to neutrophils.
    Chow TY; Juby C; Brousseau R
    Antisense Res Dev; 1994; 4(2):81-6. PubMed ID: 7950303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human thrombocytes and leukocytes as a source of some of the acid mucopolysaccharides of serum.
    KERBY GP; LANGLEY NM
    J Lab Clin Med; 1959 May; 53(5):708-13. PubMed ID: 13654911
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma glycosaminoglycans in normal individuals of various age.
    Singh J; Di Ferrante N; Gyorkey F; Wilson N
    Atherosclerosis; 1977 Nov; 28(3):319-24. PubMed ID: 597344
    [No Abstract]   [Full Text] [Related]  

  • 35. Monocyte-derived macrophages: an in vitro system for studying hereditary lysosomal storage diseases.
    Yatziv S; Epstein LB; Epstein CJ
    Pediatr Res; 1978 Sep; 12(9):939-44. PubMed ID: 152426
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemical studies of mucopolysaccharides of rat blood platelets.
    ANDERSON B; ODELL TT
    Proc Soc Exp Biol Med; 1958 Dec; 99(3):765-8. PubMed ID: 13614497
    [No Abstract]   [Full Text] [Related]  

  • 37. Isolation of sulfated mucopolysaccharide from blood platelets of rats.
    ANDERSON B; ODELL TT
    Proc Soc Exp Biol Med; 1957 Jan; 94(1):151-6. PubMed ID: 13400898
    [No Abstract]   [Full Text] [Related]  

  • 38. Development and use of sulodexide in vascular diseases: implications for treatment.
    Coccheri S; Mannello F
    Drug Des Devel Ther; 2013 Dec; 8():49-65. PubMed ID: 24391440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between glycosaminoglycans, platelets, and leukocytes.
    Cerletti C; Rajtar G; Marchi E; de Gaetano G
    Semin Thromb Hemost; 1994; 20(3):245-53. PubMed ID: 7824958
    [No Abstract]   [Full Text] [Related]  

  • 40. G protein activation and mediator release from human neutrophils and platelets after stimulation with sodium fluoride and receptor-mediated stimuli.
    Brom C; Brom J; König W
    Immunology; 1991 Jul; 73(3):287-92. PubMed ID: 1652553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.